Less Ads, More Data, More Tools Register for FREE

U.S. to approve of Pfizer COVID-19 vaccine in coming days -Azar

Fri, 11th Dec 2020 12:33

WASHINGTON, Dec 11 (Reuters) - U.S. approval of Pfizer Inc's
experimental COVID-19 vaccine should come within days,
with the first Americans getting immunized as early as Monday or
Tuesday, U.S. Health and Human Services Secretary Alex Azar said
on Friday.

Azar, speaking on ABC News's "Good Morning America" program,
added that the FDA had informed the drugmaker it planned to move
forward toward authorization. The federal government would also
work with the company to get the vaccine shipped out, he added.
(Reporting by Susan Heavey; Editing by Hugh Lawson)

Related Shares

More News
Today 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Today 07:48

LONDON BRIEFING: Astra gets US drug approval; Ascential trades in line

(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Ba...

Today 07:23

IN BRIEF: AstraZeneca gets positive cancer test results for Calquence

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Reports promising test results for one of its cancer therapies. The Echo phase III t...

Today 07:15

AstraZeneca's Imfinzi gets US approval for endometrial cancer patients

(Sharecast News) - AstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or ...

12 Jun 2024 20:56

AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes

(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.